Financial Analyses
Notice: The opinions below stem from detailed analyses, to which the reader is invited to refer for his own satisfaction. In addition, recommendations made by analysts/journalists are purely personal commitments and do not constitute a statement or a forecast by the EQUASENS Group. Under no circumstances can the EQUASENS Group be held liable for information or data contained in or omitted from this page. These opinions are provided purely for information and are not in any way an invitation or incentive to engage in transactions.
06/11/2025
Q3 Sales – Acceleration of organic growth (Gilbert Dupont analysis)
05/11/2025
Q3 Sales – Recovery confirmed (GreenSome Finance analysis)
05/11/2025
2025 Q3 revenue
29/09/2025
2025 H1 results – investments continue (GreenSome Finance analysis)
01/08/2025
H1 Sales – Organic growth accelerated in Q2 (Gilbert Dupont Analysis)
01/08/2025
H1 Sales – Momentum confirmed (Greensome Finance Analysis)
01/07/2025
Acquisitions – Strengthening of Axigate Link (GreenSome Finance analysis)
06/06/2025
Q1 Sales – The recovery is taking shape (GreenSome Finance Analysis)
21/05/2025
Good Q1, especially for Pharmagest (Gilbert Dupont Analysis)
31/03/2025
2024 Annual Results – Investments will continue (Greensome Finance analysis)
07/02/2025
2024 Annual Sales – Close to forecasts (a Gilbert Dupont analysis)
07/02/2025
2024 Annual Sales – The sequence improves (a GreenSome Finance analysis)
07/01/2025
CALIMED acquisition – The network expansion continues (a GreenSome Finance analysis)
15/11/2024
Q3 2024 Revenues – No organic rebound expected in Q4 (Gilbert Dupont Analysis)
12/11/2024
Q3 Sales – Better performance (GreenSome Finance Analysis)
02/10/2024
2024 H1 Results (Gilbert Dupont Analysis)
02/10/2024
2024 H1 Results (Greensome Finance Analysis)
05/08/2024
2024 H1 Revenues – Return to growth expected in H2 (Gilbert Dupont Analysis)
05/08/2024
2024 Q2 Sales – Slight decline in Q2 as expected (GreenSome Finance Analysis)
14/05/2024
2024 Q1 Sales – Tense start of the year (GreenSome Finance Analysis)
02/04/2024
2023 Annual Results – 2025, shifting gears ? (Greensome Finance Analysis)
06/02/2024
Sales 2023 – The Ségur, a disruptive factor (Greensome Analysis)
04/01/2024
